Acer has to conduct new trial of rare disease drug, FDA says
Shares of the company fell dramatically Tuesday after it announced that the agency had rejected its application for the drug celiprolol in vascular Ehlers-Danlos syndrome.
Cambridge startup raises $2.1M to develop first drug for Maple Syrup Urine Disease
Cambridge startup Acer Therapeutics is developing the first therapy for a rare inherited condition called Maple Syrup Urine Disease. Known for causing neurological and social impairment, MSUD gets its unique name from the urine’s distinctive smell of maple syrup – all thanks to a defect in an individual’s amino acid metabolism. The company just raised $2.1 million, according […]
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.